Simone Sep

Simone Sep

Auto-generated profile, based on publicly available information

Simone Sep

Maastricht University Medical Center, Maastricht, The Netherlands

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
EJEveline P.C.J. Janssen
Eveline P.C.J. Janssen
SKSebastian Köhler
Sebastian Köhler
Anouk GeraetsAnouk Geraets
Anouk Geraets
CSCoen D.A. Stehouwer
Coen D.A. Stehouwer
NSNicolaas Schaper
Nicolaas Schaper
MSMiranda T. Schram
Miranda T. Schram
Low-grade inflammation (LGI) and endothelial dysfunction (ED) might play a key role in the development of depression. We investigated the associations and mediation of LGI and ED with four-year incidence and course of depressive symptoms (remitted, recurrent or persistent). In this prospective cohort study (mean age 59.6 ± 8.2 years, 48.9% women, 26.6% diabetes by design), Cox and multinomial regression analyses, adjusted for age, sex, educational level and diabetes status were used to investigate the associations of LGI and ED with onset and course of depressive symptoms as assessed by the PHQ-9 questionnaire. During 10,847 person-years of follow-up, 264 participants developed incident depression. Higher levels of LGI (OR [95%CI] per SD 1.32[1.16-1.49], p < 0.001) and ED (1.26[1.11-1.43], p < 0.001) were associated with incident depressive symptoms. In mediation analysis, 60% of the total effect of ED with incident depressive symptoms could be attributed to LGI. 76 out of 2637 participants had a persistent course of depressive symptoms. Higher levels of LGI (1.75[1.40-2.19], p < 0.001) and ED (1.33[1.04-1.71], p = 0.021) were associated with a persistent course of depressive symptoms. Higher ED was more strongly associated with persistent depressive symptoms (1.33[1.04-1.71], p = 0.021), while LGI was associated with remission of depression symptoms. LGI and ED were both associated with incident depressive symptoms, where the latter association was substantially mediated by LGI. ED was further associated with a persistent course of depressive symptoms, while LGI was not. These results suggest a temporal, vascular contribution of both LGI and ED to the etiology and chronicity of depressive symptoms.

1 March 2010 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
SSSimone Sep
Simone Sep
JVJef Verbeek
Jef Verbeek
GKGerardus Koek
Gerardus Koek
LSLuc Smits
Luc Smits
MSMarc Spaanderman
Marc Spaanderman
LPLouis Peeters
Louis Peeters

1 January 2009 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
SSSimone J. S. Sep
Simone J. S. Sep
LSLuc J. M. Smits
Luc J. M. Smits
MPMartin H. Prins
Martin H. Prins
MSMarc E. A. Spaanderman
Marc E. A. Spaanderman
LPLouis L. H. Peeters
Louis L. H. Peeters

5 November 2009 in Hypertension in Pregnancy
Verified
Journal Article
Closed access
PDF file
SSSimone Sep
Simone Sep
LSLuc Smits
Luc Smits
MPMartin Prins
Martin Prins
LPLouis Peeters
Louis Peeters
Objective. To summarize reported evidence on the performance and clinical usefulness of prediction tests for recurrent hypertensive disease in pregnancy. Methods. A literature search was conducted in MEDLINE/PubMed and EMBASE. Test characteristics were extracted for relevant reports. Results. Thirty-three of 4,311 articles found met the inclusion criteria. Twenty-four potential predictors were identified. Pre-pregnant plasma volume, uterine-artery blood flow velocity profiles, and combined longitudinal patterns of in-pregnancy laboratory variables had reasonable predictive capacity, but also some practical shortcomings. Confidence intervals were often wide. Conclusions. Although evidence points to promising predictive accuracy of some tests, immediate applicability is hampered by statistical imprecision and clinical drawbacks.

11 October 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
CWCarolina M H Wiertz
Carolina M H Wiertz
TMThijs van Meulenbroek
Thijs van Meulenbroek
CLCynthia Lamper
Cynthia Lamper
BHBea Hemmen
Bea Hemmen
SSSimone Sep
Simone Sep
JVJeanine Verbunt
Jeanine Verbunt
Background: Patients with post–COVID-19 condition (PCC) experience a wide range of complaints (physical, cognitive, and mental), sometimes with high levels of disability in daily activities. Evidence of effective interdisciplinary rehabilitation treatment is lacking. A person-centered, biopsychosocial, interdisciplinary rehabilitation program, adapted to expert opinions and the patient’s needs, was therefore developed. Objective: This study aims to present a study protocol for a clinical trial to evaluate the effect of a new, person-centered, interdisciplinary rehabilitation treatment for PCC. It is aimed at improving participation in society and health-related quality of life in patients with PCC who perceive a high level of disability in daily activities or participation. Methods: A total of 20 Dutch adults, aged 18 years or older, with high levels of disability in daily activities and participation in society will be included in this replicated and randomized single-case experimental design study, from October 2023 onward. The replicated and randomized single-case experimental design consists of 3 phases. The baseline phase is the observational period, in which no specific treatment will be given. In the intervention phase, patients will receive the new outpatient treatment 3 times a week for 12 weeks, followed by a 12-week follow-up phase. During the intervention phase, the treatment will be personalized according to the patient’s physical, mental, and cognitive symptoms and goals. The treatment team can consist of a rehabilitation physician, physiotherapist, occupational therapist, speech therapist, and psychologist. The primary outcomes of the study are daily diaries, which consist of 8 questions selected from validated questionnaires (Utrecht Scale for Evaluation of Rehabilitation-Participation, EQ-5D-5L, and the Hospital Anxiety and Depression Scale). The other primary outcome measurements are participation in society (Utrecht Scale for Evaluation of Rehabilitation-Participation) and health-related quality of life (EQ-5D-5L). The secondary outcomes are physical tests and validated questionnaires aimed at physical, mental, and cognitive complaints. Effect evaluation based on daily assessments will include visual analysis, calculation of effect sizes (Nonoverlap of All Pairs), randomization tests, and multilevel analysis. In addition, other analyses will be based on ANOVA or a 2-tailed Student t test. Results: Data collection for this study started in October 2023 and is planned to be completed in July 2024. The results will be published in peer-reviewed journals and presented at international conferences. Conclusions: This is the first study investigating the effect of an interdisciplinary rehabilitation treatment with a person-centered, biopsychosocial approach in patients with PCC. Our findings will help to improve the treatment and support of patients with PCC. Trial Registration: German Clinical Trials Register DRKS00032636; https://drks.de/search/en/trial/DRKS00032636 International Registered Report Identifier (IRRID): DERR1-10.2196/63951

1 June 2018 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
KDK. Denissen
K. Denissen
ABA. Boonen
A. Boonen
JNJ. Nielen
J. Nielen
AFA. Feitsma
A. Feitsma
EHE. van Den Heuvel
E. van Den Heuvel
Simone EussenSimone Eussen
Simone Eussen
Background Observational studies showed inverse associations between milk consumption and knee osteoarthritis (knee OA).1, 2 There is lack of information on the role of specific other dairy product categories. Objectives To explore the association between dairy consumption and presence of clinical knee OA in individuals aged 40–75 year participating in the Maastricht Study. Methods Presence of clinical knee OA was defined according to a slightly modified version of the American College of Rheumatology (ACR) clinical classification criteria.3 Data on dairy consumption was appraised by a 253-item Food Frequency Questionnaire covering 47 dairy products with categorization on fat content, fermentation or dairy type. Multivariable logistic regression analyses were performed to estimate odd ratios (ORs) and 95% confidence intervals (95% CI), while correcting for relevant factors. Results Of the 3010 participants included in this study, 427 individuals (14%) were classified as having clinical knee OA. Significant inverse associations were observed between presence of clinical knee OA and intake of full-fat dairy and Dutch, primarily semi-hard, cheese, with OR for the highest compared to the lowest tertile of intake of 0.68 (95%CI 0.50–0.92) for full-fat dairy, and 0.75 (95%CI 0.56–0.99) for Dutch cheese. No significant associations were found for other dairy product categories. Conclusions In this Dutch population, higher intake of full-fat dairy and Dutch cheese, but not milk, was cross-sectionally associated with lower presence of clinical knee OA. Prospective studies need to assess the relationship between dairy consumption, and in particular semi-hard cheeses, with incident knee OA. References [1] Kacar C, et al. Clin Exp Rheumatol. 2004;22(4):473–6. [2] Lu B, et al. Arthritis Care Res. 2014;66(6):802–9. [3] Altman R, et al. Arthritis Rheum. 1986;29(8):1039–49. Acknowledgements The authors thank all the voluntary participants from the Maastricht Study as well as the funding bodies. Disclosure of Interest K. Denissen: None declared, A. Boonen: None declared, J. Nielen: None declared, A. Feitsma Employee of: FrieslandCampina, a dairy company, E. van den Heuvel Employee of: FrieslandCampina, a dairy company, P. Emans: None declared, S. Sep: None declared, C. Stehouwer: None declared, M. van Dongen: None declared, P. Dagnelie: None declared, S. Eussen: None declared